Clinical Trials
21 trialsNCT04771871 2026-05-07
TARMAC
University College Hospital, Ibadan
Phase 2 Recruiting
NCT06067503 2026-04-13
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
NCT02958852 2025-09-10
ABC-SE
Lund University Hospital
Phase 2 Completed
NCT02035813 2024-06-04
DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
University of Ulm
Phase 2 Completed
NCT05637567 2023-11-13
ASAP
German Cancer Research Center
Phase 2 Not yet recruiting
NCT04648189 2023-10-19
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
The Netherlands Cancer Institute
Phase 2 Withdrawn
NCT02707159 2023-03-08
PACT-ACT-v6
Helse Stavanger HF
Phase 2 Completed
NCT04168931 2023-01-17
GASTHER2
AC Camargo Cancer Center
Phase 2 Terminated
NCT05502458 2022-08-16
Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor
Zhejiang Cancer Hospital
Phase 2 Completed
NCT03101046 2022-02-10
TACTIK
UNICANCER
Phase 2 Completed
NCT03050866 2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2 Unknown
NCT04993014 2021-08-06
HER2Cell
AC Camargo Cancer Center
Phase 2 Recruiting
NCT03957564 2020-01-22
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer
Affiliated Hospital of Qinghai University
Phase 2 Unknown
NCT01640444 2019-04-11
VISNU-2
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 2 Completed
NCT01548677 2019-03-13
TREAT-CTC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT03070002 2018-11-20
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
Northwestern University
Phase 2 Terminated
NCT02621190 2016-08-17
CARVE
Erasmus Medical Center
Phase 2 Withdrawn
NCT01565837 2016-02-01
SART
Comprehensive Cancer Centers of Nevada
Phase 2 Unknown
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT02065323 2015-01-19
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Comprehensive Cancer Centers of Nevada
Phase 2 Withdrawn
NCT00429182 2013-04-10
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed